AI-driven virtual screening uncovers two potent CDK9 inhibitors with anticancer effects in lab tests

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the Sbarro Institute in Philadelphia, the National Cancer Institute—Pascale Foundation, and the University of Pisa.

Continue Reading

News Source: medicalxpress.com